Drug Filter >
  • Targets: Anaplastic lymphoma kinase
  •   > 
Drug Filter
Status:
Approved (3) NDA Filing (1) Phase Ⅲ (1) Phase Ⅱ (3) Phase Ⅰ (7)
Clinical Stage:
Active (11) Discontinued (1)
Company:
Pfizer (2) Amgen (1) Ariad Pharmaceuticals (1) Astellas (1) Betta (1) Centaurus Biopharma (1) Chugai (1) Eternity Bioscience (1) Fosun Pharma (1) Hansoh Pharma (1) Ignyta (1) MedPacto (1) Nerviano Medical Sciences (1) Novartis (1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (1) Tesaro (1) Teva (1) Xcovery (1) 未知 (0)
Indication:
Lung cancer (1) Lymphoma (1) Non small cell lung cancer (NSCLC) (10) Solid tumours (4) Colorectal cancer (1) B-cell lymphoma (1) Central nervous system tumors (1)
Country:
Aprv. Year:
2014 (2) 2011 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码